Lincoln Pharmaceuticals Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Lincoln Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
57.06% Gain from 52W Low
2.3
TTM PE Ratio
Below industry Median
13.2
Price to Book Ratio
Below industry Median
2.1
Dividend yield 1yr %
Below industry Median
0.2
TTM PEG Ratio
PEG TTM is less than 1
0.5
RSI
RSI is mid-range
59
MFI
MFI is mid-range
66.2

Lincoln Pharmaceuticals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Lincoln Pharmaceuticals Ltd shareholding Pattern

Promoter
49.5%
Foreign Institutions
3.9%
Public
46.5%
Promoter
49.8%
Foreign Institutions
3.2%
Domestic Institutions
0.1%
Public
46.9%
Promoter
50.5%
Foreign Institutions
2.6%
Public
46.9%
Promoter
48.7%
Foreign Institutions
1.7%
Public
49.6%
Promoter
47%
Foreign Institutions
1.3%
Public
51.7%
Promoter
46.3%
Foreign Institutions
1.4%
Public
52.2%

Lincoln Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
612.20
10Day EMA
607.50
12Day EMA
605.40
20Day EMA
598.90
26Day EMA
596.20
50Day EMA
595.60
100Day EMA
598.70
200Day EMA
574.80
5Day SMA
609.90
10Day SMA
613.40
20Day SMA
592.10
30Day SMA
586.50
50Day SMA
587.20
100Day SMA
613.10
150Day SMA
624.40
200Day SMA
597.70
Delivery & Volume
Resistance & Support
614.30
Pivot
Resistance
First Resistance
623.10
Second Resistance
630.60
Third Resistance
639.40
Support
First Support
606.80
Second support
598
Third Support
590.50
Relative Strength Index
59
Money Flow Index
66.16
MACD
9.19
MACD Signal
6.56
Average True Range
19.33
Average Directional Index
19.89
Rate of Change (21)
8.38
Rate of Change (125)
-0.15
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Kopran Ltd.
1230.58
159.7
292.3
Syncom Formulation (India) Ltd.
-
-
-
NGL Fine - Chem Ltd.
1502.23
1630
2823.9
Beta Drugs Ltd.
-
-
-
Zota Healthcare Ltd.
1461.28
360.1
645
Windlas Biotech Ltd.
1499.49
295.55
794.5

Lincoln Pharmaceuticals Ltd Company background

Founded in: 1995
Managing director: Mahendra G Patel
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake inhouse testing of its products for better quality control and RD. It came out with a public issue in Feb.96 to partfinance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 202122, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.
Read More

Lincoln Pharmaceuticals Ltd FAQs

Lincoln Pharmaceuticals Ltd shares are currently priced at 615.6 on NSE and 614.15 on BSE as of 6/21/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Lincoln Pharmaceuticals Ltd [LINCOLN] share was 51.83. The Lincoln Pharmaceuticals Ltd [LINCOLN] share hit a 1-year low of Rs. 391.95 and a 1-year high of Rs. 755.15.

The market cap of Lincoln Pharmaceuticals Ltd is Rs. 1233.03 Cr. as of 6/21/2024 12:00:00 AM.

The PE ratios of Lincoln Pharmaceuticals Ltd is 13.18 as of 6/21/2024 12:00:00 AM.

The PB ratios of Lincoln Pharmaceuticals Ltd is 2.07 as of 6/21/2024 12:00:00 AM

You can easily buy Lincoln Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage